Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 17, 2009Antimicrobial Agents and ChemotherapyOpen Access

Efficacy of Posaconazole against Three Clinical Aspergillus fumigatus Isolates with Mutations in the cyp51A Gene

View Full Paper
Ask AI
Bookmark
Share

Authors

EMEleftheria MavridouPanagiotis & Aglaia Kyriakou Children's HospitalRBRoger J. M. BrüggemannRadboud University NijmegenWMWillem J. G. MelchersStatens Serum Institut

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mavridou et al. (2009) studied this question.

synapsesocial.com/papers/6a6d341835aa2c282cdfd35ehttps://doi.org/10.1128/aac.00931-09
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure12009 · 758 citations
  2. 2Itraconazole resistance in Aspergillus fumigatus1997 · 514 citations
  3. 3Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-19901993 · 1,147 citations
  4. 4A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A Alterations2007 · 503 citations
  5. 5Substitutions at Methionine 220 in the 14α-Sterol Demethylase (Cyp51A) of Aspergillus fumigatus Are Responsible for Resistance In Vitro to Azole Antifungal Drugs2004 · 212 citations